Fusion Pharmaceuticals Inc (FUSN)
21.51
+0.08
(+0.37%)
USD |
NASDAQ |
May 15, 15:17
Fusion Pharmaceuticals Free Cash Flow: -87.67M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -87.67M |
| December 31, 2023 | -85.69M |
| September 30, 2023 | -86.58M |
| June 30, 2023 | -89.11M |
| March 31, 2023 | -86.51M |
| December 31, 2022 | -75.42M |
| September 30, 2022 | -71.97M |
| June 30, 2022 | -71.79M |
| March 31, 2022 | -71.62M |
| Date | Value |
|---|---|
| December 31, 2021 | -77.23M |
| September 30, 2021 | -63.51M |
| June 30, 2021 | -55.39M |
| March 31, 2021 | -44.24M |
| December 31, 2020 | -30.89M |
| September 30, 2020 | -31.70M |
| June 30, 2020 | -21.36M |
| March 31, 2020 | -19.11M |
| December 31, 2019 | -14.15M |
Free Cash Flow Range, Past 5 Years
-89.11M
Minimum
Jun 2023
-14.15M
Maximum
Dec 2019
-60.22M
Average
-71.70M
Median
Free Cash Flow Benchmarks
| AstraZeneca PLC | 5.785B |
| Landos Biopharma Inc | -20.80M |
| Perspective Therapeutics Inc | -37.98M |
| Acasti Pharma Inc | -13.57M |
| Aurinia Pharmaceuticals Inc | -34.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.31M |
| Cash from Investing (Quarterly) | -70.37M |
| Cash from Financing (Quarterly) | 64.01M |
| Free Cash Flow Per Share (Quarterly) | -0.3419 |
| Free Cash Flow Yield | -5.58% |